York County-based Unilife Corp. ended its fiscal year June 30 with a net loss of $57.9 million, according to a regulatory filing.
That’s an improvement from the previous year’s net loss of $63.2 million, the filing says, largely because revenue climbed to $14.7 million from $2.7 million. However, the company also increased its research and development spending, investing “over half of total cash operating expenses” to R&D in FY 2014.
As of June 30, the company had 134 patents worldwide, up 40 percent from the previous year, the filing said, and more than 200 additional patent applications are at various stages of examination. It also noted the company filed 62 patent applications in FY 2014, a 55 percent increase from 2013.
The filing also said Unilife employs 209 people, “virtually all” based in York and King of Prussia and 80 percent of them “engaged in operational activities including research and development, quality assurance and manufacturing.”
As of June 30, Unilife said, it had 12 active programs with 11 customers, “with additional contracts in the final stages of formalization” and many current customers and active programs remaining confidential.